Vincristine increased spinal cord substance P levels in a peripheral neuropathy rat model
- PMID: 31899978
- DOI: 10.1080/01480545.2019.1706547
Vincristine increased spinal cord substance P levels in a peripheral neuropathy rat model
Abstract
Chemotherapy-induced peripheral neuropathy has an important impact on the quality of life of cancer patients. Vincristine-induced neuropathy is a major dose-limiting side effect. Symptoms of peripheral neuropathy are spontaneous pain, allodynia, and hyperalgesia. To analyze the contribution of substance P to the development of vincristine-induced mechanical allodynia/hyperalgesia, substance P levels in the rat spinal dorsal horn were analyzed after vincristine treatment. Mechanical allodynia/hyperalgesia was tested with the von Frey filaments 14 days after intraperitoneal (i.p.) administration of vincristine 0.1 mg/kg/day in rats. Vincristine-induced mechanical allodynia/hyperalgesia after day 14 was significantly inhibited by the neurokinin 1 receptor antagonist, aprepitant (20 mg/kg, s.c.). Immunohistochemistry showed that vincristine treatment significantly increased substance P expression (30.3% ± 2.4%) compared to saline treatment in the superficial layers of the spinal dorsal horn. Moreover, vincristine treatment significantly increased the substance P level in the spinal cord. These results suggest that vincristine treatment increases substance P in the spinal dorsal horn, and that aprepitant attenuates mechanical allodynia/hyperalgesia in vincristine-induced neuropathic rats.
Keywords: Vincristine; aprepitant; peripheral neuropathic pain; spinal cord; substance P.
Similar articles
-
Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy.Korean J Anesthesiol. 2020 Oct;73(5):434-444. doi: 10.4097/kja.19481. Epub 2020 Feb 12. Korean J Anesthesiol. 2020. PMID: 32046474 Free PMC article.
-
Vincristine-induced peripheral neuropathic pain and expression of transient receptor potential vanilloid 1 in rat.J Pharmacol Sci. 2017 Apr;133(4):254-260. doi: 10.1016/j.jphs.2017.03.004. Epub 2017 Mar 30. J Pharmacol Sci. 2017. PMID: 28410966
-
Paclitaxel-induced peripheral neuropathy increases substance P release in rat spinal cord.Eur J Pharmacol. 2016 Jan 5;770:46-51. doi: 10.1016/j.ejphar.2015.11.055. Epub 2015 Nov 30. Eur J Pharmacol. 2016. PMID: 26658369
-
EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn.Mol Pain. 2016 Jun 15;12:1744806916657089. doi: 10.1177/1744806916657089. Print 2016. Mol Pain. 2016. PMID: 27306413 Free PMC article.
-
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.Pain. 2004 May;109(1-2):150-61. doi: 10.1016/j.pain.2004.01.029. Pain. 2004. PMID: 15082137
Cited by
-
The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects.Neurotherapeutics. 2025 Mar;22(2):e00532. doi: 10.1016/j.neurot.2025.e00532. Epub 2025 Feb 12. Neurotherapeutics. 2025. PMID: 39939241 Free PMC article.
-
5,7-Dimethoxycoumarin ameliorates vincristine induced neuropathic pain: potential role of 5HT3 receptors and monoamines.Front Pharmacol. 2023 Oct 17;14:1213763. doi: 10.3389/fphar.2023.1213763. eCollection 2023. Front Pharmacol. 2023. PMID: 37920212 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
